⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL600790 | 0.96 | CXCR4 (0.53) | — | |
| SCHEMBL1779850 | 0.93 | CXCR4 (0.50) | — | |
| SCHEMBL10036 | 0.93 | — | — | |
| SCHEMBL1782168 | 0.93 | CXCR4 (0.41) | — | |
| SCHEMBL567977 | 0.90 | ALDH1A1 (0.56) | — | |
| SCHEMBL674050 | 0.87 | CXCR4 (0.53) | — | |
| SCHEMBL674177 | 0.86 | ALDH1A1 (0.60) | — | |
| SCHEMBL175198 | 0.83 | — | — | |
| SCHEMBL566326 | 0.81 | ALDH1A1 (0.53) | — | |
| SCHEMBL18687 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814698-B2 | Methods for simultaneous leaching and extraction of precious metals | EXCIR WORKS CORP. (CA) | 2023-11-14 | — | — | US | claimed |
| CN-113969358-B | Method for selectively leaching and extracting noble metals in organic solvents | 艾克希尔工厂公司 | 2023-10-20 | — | — | CN | claimed |
| US-20220340998-A1 | METHODS FOR SIMULTANEOUS LEACHING AND EXTRACTION OF PRECIOUS METALS | EXCIR WORKS CORP. (CA) | 2022-10-27 | — | — | US | claimed |
| US-11427886-B2 | Methods for simultaneous leaching and extraction of precious metals | EXCIR WORKS CORP. (CA) | 2022-08-30 | — | — | US | claimed |
| US-10087167-B2 | Benzofurans substituted with secondary benzamide as HCV inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-10-02 | — | — | US | claimed |
| WO-2018106641-A1 | PYRAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-06-14 | — | — | WO | claimed |
| EP-3177667-B1 | POLYMER HAVING ADHERENCE PROPERTIES | XANCHEM (FR) | 2018-06-06 | — | — | EP | claimed |
| US-20180142322-A1 | METHODS FOR SIMULTANEOUS LEACHING AND EXTRACTION OF PRECIOUS METALS | UNIVERSITY OF SASKATCHEWAN (CA) | 2018-05-24 | — | — | US | claimed |
| US-20180112289-A1 | METHODS FOR SELECTIVE LEACHING AND EXTRACTION OF PRECIOUS METALS IN ORGANIC SOLVENTS | UNIVERSITY OF SASKATCHEWAN (CA) | 2018-04-26 | — | — | US | claimed |
| US-20180099953-A1 | BENZOFURANS SUBSTITUTED WITH SECONDARY BENZAMIDE AS HCV INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-04-12 | — | — | US | claimed |
| EP-1218372-B1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMA (US) | 2003-07-02 | — | — | EP | claimed |
| US-20030119827-A1 | Novel nitriles useful as reversible inhibitors of cysteine proteases | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2003-06-26 | — | — | US | claimed |
| EP-0806419-B1 | Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator | MEIJI SEIKA KAISHA (JP) | 2003-04-02 | — | — | EP | claimed |
| US-20030013730-A1 | Serotonin 5-HT3 receptor partial activator | MEIJI SEIKA KAISHA, LTD. | 2003-01-16 | — | — | US | claimed |
| WO-2002100849-A2 | NOVEL NITRILES USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | claimed |
| US-20020058809-A1 | Compounds useful as reversible inhibitors of cysteine proteases | EMMANUEL MICHEL JOSE (US) | 2002-05-16 | — | — | US | claimed |
| US-20010016579-A1 | Serotonin 5-HT, receptor partial activator | LOTUS PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | US | claimed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| EP-0806419-A1 | Benzoxazole derivatives as serotonin 5-HT3 receptor partial activator | MEIJI SEIKA KAISHA LTD. (JP) | 1997-11-12 | — | — | EP | claimed |